INAD, or Infantile Neuroaxonal Dystrophy, is a rare disease that impacts a few hundred children across the world. but learning and treating the disease could have much broader implications. Deborah Vauclare, Co-Founder of Bisous For Léo, joined Cheddar to discuss the latest clinical trial.